Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Submitted by
admin
on April 23, 2013 - 3:30pm
Source:
Yahoo/Minyanville
News Tags:
Medivation
Aragon
ARN-509
prostate cancer
Headline:
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Do Not Allow Advertisers to Use My Personal information
